Advanced age is associated with lack of administration of adjuvant chemotherapy for completely resected stage IB-III non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Riely, Gregory J. [1 ]
Seshan, V. E. [1 ]
Azzoli, C. G. [1 ]
Kris, Mark G. [1 ]
Rusch, Valerie W. [1 ]
Park, Bernard K. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2007年 / 2卷 / 08期
关键词：
D O I：
10.1097/01.JTO.0000283386.16704.e8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S454 / S454
页数：1
相关论文
共 50 条
  • [1] ADJUVANT CHEMOTHERAPY IN RESECTED STAGE IB-III NON SMALL CELL LUNG CANCER
    Zhang, B.
    Wong, H-L
    Gunawardana, D.
    Parente, P.
    de Boer, R.
    Barling, A.
    Antippa, P.
    Wong, R.
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (04) : S32 - S32
  • [2] Adjuvant Chemotherapy is Effective for Completely Resected Stage IB Non-Small Cell Lung Cancer
    Nakata, M.
    Nojima, Y.
    Nanba, K.
    Saisho, S.
    Shimizu, K.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S845 - S846
  • [3] Efficacy of Adjuvant Chemotherapy for Completely Resected Stage IB Non-Small Cell Lung Cancer
    Byun, M. K.
    Park, H. J.
    Park, H. S.
    Jeung, H.
    Cho, J. Y.
    Lee, S. S.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1982 - S1982
  • [4] Adjuvant chemotherapy of completely resected early stage non-small cell lung cancer (NSCLC)
    Liang, Ying
    Wakelee, Heather A.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2013, 2 (05) : 403 - 410
  • [5] Efficacy of adjuvant chemotherapy for completely resected stage IB non-small cell lung cancer: a retrospective study
    Park, Hye Jung
    Park, Heae Surng
    Cha, Yoon Jin
    Lee, Sungsoo
    Jeung, Hei-Cheul
    Cho, Jae Yong
    Kim, Hyung Jung
    Byun, Min Kwang
    JOURNAL OF THORACIC DISEASE, 2018, 10 (04) : 2279 - 2287
  • [6] A feasibility study of adjuvant carboplatin (C) plus gemcitabine (G) in completely resected stage IB-III non-small-cell lung cancer (NSCLC)
    Horiike, A.
    Ohyanagi, F.
    Okano, Y.
    Satoh, Y.
    Okumura, S.
    Ishikawa, Y.
    Nakagawa, K.
    Horai, T.
    Nishio, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] Adjuvant chemotherapy or immunotherapy for completely resected stage IB non-small cell lung cancer: still a grey zone?
    Lee, Kuan-Yu
    Hsu, Chen-Xiong
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (03) : 647 - 648
  • [8] Adjuvant chemotherapy in completely resected stage III-N2 non-small cell lung cancer
    Wang, S.
    Ou, W.
    Sun, H.
    Yang, H.
    Ye, X.
    Fang, Q.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [9] Is Advanced Age a Prognostic Factor for Adjuvant Chemotherapy in Completely Resected Non-Small-Cell Lung Cancer (NSCLC)?
    Batum, O.
    Anar, C.
    Ozdogan, Y.
    Ermin, S.
    Yilmaz, U.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [10] Community-based evaluation of determinants for outcome of completely resected non-small cell lung cancer (NSCLC) stage IB receiving adjuvant chemotherapy
    Wallerek, S.
    Ravn, J.
    Sorensen, J. B.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S812 - S812
12345